Regulation Of B16F1 melanoma cell metastasis by inducible functions of the hepatic microvasculature

• Published in: European journal of cancer (1990) 2002-06, Vol.38 (9), p.1261-1270
• Main Authors: Wang, H.H., McIntosh, A.R., Hasinoff, B.B., MacNeil, B., Rector, E., Nance, D.M., Orr, F.W.
• Format: Article
• Language: English
• Subjects: Animals; Apoptosis; Biological and medical sciences; Cell Adhesion Molecules - metabolism; Endothelium; Female; Hepatic sinusoid, lipopolysaccharide; Lipopolysaccharides - pharmacology; Liver; Liver - metabolism; Liver Neoplasms - blood supply; Liver Neoplasms - secondary; Medical sciences; Melanoma, Experimental - blood supply; Melanoma, Experimental - secondary; Metastasis; Mice; Mice, Inbred C57BL; Microcirculation; Microvascular adhesion molecules; Multiple tumors. Solid tumors. Tumors in childhood (general aspects); Neoplasm Proteins - metabolism; Nitric oxide; Nitric Oxide - metabolism; Nitric Oxide Synthase - metabolism; Nitric Oxide Synthase Type II; Tumor Cells, Cultured; Tumors; Tumour cell cytotoxicity
• ISSN: 0959-8049; 1879-0852
• DOI: 10.1016/S0959-8049(02)00039-4

We have previously shown that circulating intravascular cells generally arrest by mechanical restriction in the hepatic sinusoids, causing rapid release of nitric oxide (NO) which is cytotoxic to these cells and inhibits their growth into metastatic tumours. Here, we present evidence that these NO-dependent cytotoxic mechanisms are susceptible to upregulation by lipopolysaccharide (LPS). Five×105 fluorescently labelled melanoma cells were injected into the mesenteric vein of C57BL/6 mice to effect their localisation in the hepatic microvasculature. Test mice were then given 1 mg/kg LPS intraperitoneally (i.p.) to activate the microvascular cells. By electron paramagnetic resonance (EPR) spectroscopy, the expression of NO in the liver was significantly increased by 8 h in the LPS-treated mice. The non-selective NO synthase inhibitor L-NAME inhibited the induction of NO by LPS, while its inactive enantiomer D-NAME had no significant effect. Using immunohistochemistry (IHC), iNOS-positive microvascular cells were detected in the terminal portal venule (TPV) region of the liver 8 h after LPS stimulation. LPS treatment also increased the retention of melanoma cells in the liver between 8 and 24 h, especially in the TPV region. Eight hours after cell injection, local expression of VCAM-1 and ICAM-1 was detected by double-label immunohistochemistry at the sites of tumour cell arrest. Expression of these adhesion molecules was enhanced in mice treated with LPS. Using flow cytometry, 98% of the B16F1 melanoma cells expressed VLA-4, the counter receptor of VCAM-1, and approximately 1.5% expressed LFA-1, the counter receptor of ICAM-1. LPS did not significantly alter the expression of either counter receptor on melanoma cells in vitro or in vivo. By DNA end-labelling, the rates of melanoma cell apoptosis were significantly increased from 8 to 24 h in the TPV region (but not in the sinusoids) of LPS-treated mice. Fourteen days after tumour cell injection, the LPS-treated mice had a significantly smaller hepatic metastatic tumour burden than the control mice. These data suggest that LPS can inhibit the metastasis of melanoma cells in the liver by inducing the expression of NO and adhesion molecules by the hepatic endothelium. The induction of iNOS and the inducible cytotoxic effect of LPS appear to be primarily located within the TPV region of the liver acinus.